期刊文献+
共找到24篇文章
< 1 2 >
每页显示 20 50 100
Loco-regional intervention for hepatocellular carcinoma 被引量:32
1
作者 Wan Yee Lau Eric C.H.Lai 《Journal of Interventional Medicine》 2019年第2期43-46,共4页
Anatomic location/size and number of lesions,inadequate volume of future liver remnant,or poor coexisting premorbid conditions preclude surgery in the majority of patients with hepatocellular carcinoma(HCC).Liver tran... Anatomic location/size and number of lesions,inadequate volume of future liver remnant,or poor coexisting premorbid conditions preclude surgery in the majority of patients with hepatocellular carcinoma(HCC).Liver transplantation can cure some patients with poor liver function,but few patients are eligible because of scarcity of donors.Without specific anti-cancer treatment,the prognosis of HCC is poor.Various locoregional therapies are used to treat patients who are not candidates for surgery,and have emerged as tools for palliation,tumor downstaging,and bridging therapy prior to liver transplantation.Currently,local ablative therapy even competes with partial hepatectomy and liver transplantation as a primary treatment for small HCC.HCC is well suited to treatment with loco-regional therapy because it has a tendency to stay within the liver,with distant metastasis generally occurring late in the course of disease.This suggests that an effective local-regional therapy can have a great impact on HCC patients who are not candidates for surgical treatment.Loco-regional therapy can further be justified because patients with HCC usually die of liver failure consequent to intrahepatic growth resulting in liver tissue destruction,rather than extrahepatic metastases. 展开更多
关键词 HEPATOCELLULAR carcinoma HEPATECTOMY loco-regional therapy TACE Local ablation
下载PDF
Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread 被引量:14
2
作者 Amit Nandan Dhar Dwivedi Shivi Jain Ruhi Dixit 《World Journal of Clinical Cases》 SCIE 2015年第3期231-244,共14页
The most common malignancy of biliary tract is gallbladder cancer(GBC) which is the third most common cancer in gastrointestinal tract. It is a lethal disease for most patients in spite of growing awareness and improv... The most common malignancy of biliary tract is gallbladder cancer(GBC) which is the third most common cancer in gastrointestinal tract. It is a lethal disease for most patients in spite of growing awareness and improved diagnostic techniques. GBC has a verypoor prognosis and the 5 year survival rate is < 10%. Although etiology of the carcinoma of the gallbladder is still obscure, various factors have been implicated, cholelithiasis being the most frequent. The incidence of GBC worldwide is based on the gender, geography and ethnicity which suggest that both genetic and environmental factors can cause GBC. The major route of spread of gallbladder cancer(GC) is locoregional rather than distant. It spreads by lymphatic, vascular, neural, intraperitoneal, and intraductal routes. Sonography is usually the most common imaging test to evaluate symptoms of biliary tract disease including suspected GC. With recent advances in imaging modalities like multi-detector computed tomography(CT) scanners, magnetic resonance imaging-positron emission tomography/CT diagnosis of gallbladder cancer has improved. Studies have also targeted molecular and genetic pathways. Treatment options have included extended and radical surgeries and adjuvant chemotherapy. This review article deals in detail with important aspects of carcinoma gallbladder and its manifestations and challenges. Role of various imaging modalities in characterization and accurate staging has been discussed. The loco-regional spread of this aggressive malignancy is dealt explicitly. 展开更多
关键词 GALLBLADDER cancer loco-regional and DISTANT SPREAD CHOLELITHIASIS Imaging Adenocarcinoma
下载PDF
Current status of radiofrequency ablation of hepatocellular carcinoma 被引量:7
3
作者 Hyunchul Rhim Hyo K Lim Dongil Choi 《World Journal of Gastrointestinal Surgery》 SCIE CAS 2010年第4期128-136,共9页
Loco-regional treatments for hepatocellular carcinoma(HCC) are important alternatives to curative transplantation or resection.Among them,radiofrequency ablation(RFA) is accepted as the most popular technique showing ... Loco-regional treatments for hepatocellular carcinoma(HCC) are important alternatives to curative transplantation or resection.Among them,radiofrequency ablation(RFA) is accepted as the most popular technique showing excellent local tumor control and acceptable morbidity.The current role of RFA is well documented in the evidence-based practice guidelines of European Association of Study of Liver,American Association of Study of the Liver Disease and Japanese academic societies.Several randomized controlled trials have confirmed that RFA is superior to percutaneous ethanol injections in terms of local tumor control and survival.The overall survival after RFA is comparable to after surgical resection in a selected group of patients with smaller(< 3 cm) tumors.Currently,the clinical benefits of combined RFA with transarterial chemoembolization for intermediate stage HCC are increasingly being explored.Here we review the ongoing technical advancements of RFA and future potential. 展开更多
关键词 IMAGE-GUIDED tumor ablation RADIOFREQUENCY ablation HEPATOCELLULAR CARCINOMA Thermal ablation loco-regional therapy
下载PDF
Irreversible electroporation for the management of pancreatic cancer: Current data and future directions 被引量:3
4
作者 Stavros Spiliopoulos Lazaros Reppas +4 位作者 Dimitrios Filippiadis Antonella Delvecchio Maria Conticchio Riccar do Memeo Riccardo Inchingolo 《World Journal of Gastroenterology》 SCIE CAS 2023年第2期223-231,共9页
Pancreatic cancer is currently the seventh leading cause of cancer death(4.5%of all cancer deaths)while 80%-90%of the patients suffer from unresectable disease at the time of diagnosis.Prognosis remains poor,with a me... Pancreatic cancer is currently the seventh leading cause of cancer death(4.5%of all cancer deaths)while 80%-90%of the patients suffer from unresectable disease at the time of diagnosis.Prognosis remains poor,with a mean survival up to 15 mo following systemic chemotherapy.Loco-regional thermal ablative techniques are rarely implemented due to the increased risk of thermal injury to the adjacent structures,which can lead to severe adverse events.Irreversible electroporation,a promising novel non-thermal ablative modality,has been recently introduced in clinical practice for the management of inoperable pancreatic cancer as a safer and more effective loco-regional treatment option.Experimental and initial clinical data are optimistic.This review will focus on the basic principles of IRE technology,currently available data,and future directions. 展开更多
关键词 Pancreatic cancer Interventional oncology Irreversible electroporation Ablation loco-regional treatment Image-guided treatment
下载PDF
Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy 被引量:5
5
作者 Thomas J Byrne Jorge Rakela 《World Journal of Transplantation》 2016年第2期306-313,共8页
Hepatocellular carcinoma(HCC) is a common, increasingly prevalent malignancy. For all but the smallest lesions, surgical removal of cancer via resection or liver transplantation(LT) is considered the most feasible pat... Hepatocellular carcinoma(HCC) is a common, increasingly prevalent malignancy. For all but the smallest lesions, surgical removal of cancer via resection or liver transplantation(LT) is considered the most feasible pathway to cure. Resection- even with favorable survival- is associated with a fairly high rate of recurrence, perhaps since most HCCs occur in the setting of cirrhosis. LT offers the advantage of removing not only the cancer but the diseased liver from which the cancer has arisen, and LT outperforms resection for survival with selected patients. Since time waiting for LT is time during which HCC can progress, locoregional therapy(LRT) is widely employed by transplant centers. The purpose of LRT is either to bridge patients to LT by preventing progression and waitlist dropout, or to downstage patients who slightly exceed standard eligibility criteria initially but can fall within it after treatment. Transarterial chemoembolization and radiofrequency ablation have been the most widely utilized LRTs to date, with favorable efficacy and safety as a bridge to LT(and for the former, as a downstaging modality). The list of potentially effective LRTs has expanded in recent years, and includes transarterial chemoembolization with drug-eluting beads, radioembolization and novel forms of extracorporal therapy. Herein we appraise the various LRT modalities for HCC, and their potential roles in specific clinical scenarios in patients awaiting LT. 展开更多
关键词 Liver transplantation loco-regional THERAPY Transarterial CHEMOEMBOLIZATION RADIOEMBOLIZATION Hepatocellular carcinoma
下载PDF
Postoperative Analgesia for Abdominal Laparoscopic Surgery: Tap Block vs Peri-Orificial Infiltrations
6
作者 Moustapha Diedhiou Ndiamé Sarr +5 位作者 Elhadji Boubacar Ba Abdourahmane Ndong Fallou Galass Niang Jacques Noel Tendeng Ibrahima Konaté Mohamed Lamine Fall 《Open Journal of Anesthesiology》 2023年第10期187-196,共10页
Introduction/Purpose: The “transverse abdominal plane block” or TAP block was described by Rafi in 2001. It describes an approach to the neurofascial plane of the transverse abdominal muscle via the Jean-Louis Petit... Introduction/Purpose: The “transverse abdominal plane block” or TAP block was described by Rafi in 2001. It describes an approach to the neurofascial plane of the transverse abdominal muscle via the Jean-Louis Petit triangle and provides analgesia of the entire homolateral hemi abdomen. The aim of our study was to compare post-operative analgesia and post-operative morphine requirements between transverse abdominal plane block (TAP) and peri-orificial infiltration during laparoscopic abdominal surgery. Material and method: Prospective, randomized study conducted over a 2-year period. The study was conducted in the operating theatre of the Saint Louis Regional Hospital in Senegal. All adult patients undergoing laparoscopic abdominal surgery were included. Clinical aspects, pain scales and morphine consumption were analyzed. Results: A total of 60 patients were enrolled: 30 patients in the TAP group and 30 patients in the infiltration group. The average age was 32.9 years. The indications for laparoscopy were acute appendicitis in 50% of cases, gallbladder stones in 16% and inguinal hernia in 8%. For the TAP group, the mean numerical pain scale was 3.9 at 6 hours post-operatively and 2.1 at 24 hours post-operatively. For the infiltration group, the mean numerical pain scale was 4.3 at 6 hours post-op and 3 at 24 hours post-op. Morphine consumption at 6 hours post-op was on average 0.4 mg/patient for the TAP group and 0.9 mg/patient for the infiltration group. Discussion/conclusion: Analgesia provided by ultrasound-guided TAP block for laparoscopic abdominal surgery appears to be identical to periorificial infiltration. However, the simplicity and reproducibility of ultrasound-guided TAP block gives it a definite advantage. 展开更多
关键词 loco-regional Anesthesia Post-Operative Analgesia Infiltrations LAPAROSCOPY TAP-Block
下载PDF
Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation 被引量:3
7
作者 Xian-Jie Shi, Xin Jin, Mao-Qiang Wang, Li-Xin Wei, Hui-Yi Ye, Yu-Rong Liang, Ying Luo and Jia-Hong DongDepartment of Hepatobiliary Surgery Department of Intervention Radiology Department of Pathology and Department of Radiology General Hospital of PLA, Beijing 100853, China 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2011年第2期143-150,共8页
BACKGROUND: The number of loco-regional therapies (LRTs) for hepatocellular carcinoma (HCC) has increased dramatically during the past decade. Many patients with HCC who were beyond the Milan criteria were allowed to ... BACKGROUND: The number of loco-regional therapies (LRTs) for hepatocellular carcinoma (HCC) has increased dramatically during the past decade. Many patients with HCC who were beyond the Milan criteria were allowed to receive a liver transplantation (LT) once the HCC was successfully down-staged. This retrospective study aimed to analyze the outcomes of LRTs prior to LT in patients with HCC beyond the Milan criteria. METHODS: We analyzed 56 patients treated from June 2006 to March 2010: 22 met the Milan criteria (T1+T2, 39.3%), 16 had T3 tumors (28.6%), and 11 had T4a tumors (19.6%), while 7 were suspected of tumor vascular invasion (T4b, 12.5%). All patients underwent preoperative LRTs, including transcatheter arterial chemoembolization, radiofrequency ablation, percutaneous ethanol injection, liver resection, and/or microwave coagulation therapy. The number of the patients who were successfully down-staged before LT, the types of LRTs used before LT, and their outcomes after LT were recorded. RESULTS: Eleven patients had necrotic tumors (pT0, 19.6%); 6 had pT1 tumors (10.7%), 22 had pT2 tumors (39.3%), 6 had pT3 tumors (10.7%), 5 had pT4a tumors (8.9%), and 6 had pT4b tumors (10.7%). The histopathologic tumors of 39 patients (69.6%) were down-staged and met the established Milan criteria (pT0-2). Imaging-proven under-staging was present in 5 HCC patients (8.9%) who had tumors involving the intrahepatic venous system. Twenty-three patients (41.1%) had stable HCC and 10 (17.9%) died. The 1-, 3- and 4-year survival rates were 96%, 73% and 61%, respectively, with a mean survival time of 22.29±1.63 months. Six patients died of tumorrecurrence. The 1-, 3- and 4-year recurrence-free survival (RFS) rates were 88%, 75% and 66%, respectively. The 3-year RFS of patients with pT0-2 tumors was 82%, which was markedly greater than that of patients with pT3 tumors (63%, P=0.018) or pT4 tumors (17%, P=0.000). Although the 3-year RFS of patients with pT3 tumors was greater than that of patients with pT4 tumors, the difference w 展开更多
关键词 hepatocellular carcinoma tumor down-staging loco-regional therapy liver transplantation
下载PDF
Accuracy of Ultrasound Examination of Loco-Regional Lymph Nodes in Breast Cancer Follow-Up and Its Role in the Axillary Surgical Management 被引量:1
8
作者 Jacopo Nori Icro Meattini +7 位作者 Dalmar Abdulcadir Elisabetta Giannotti Diego De Benedetto Luis Sanchez Lorenzo Orzalesi Simonetta Bianchi Leonardo Capaccioli Lorenzo Livi 《Advances in Breast Cancer Research》 2014年第1期5-11,共7页
Objective: Major international guidelines have not standardized the sequence of diagnostic examinations during the follow-up of a patient with a diagnosed breast cancer. The aim of this study is to investigate the acc... Objective: Major international guidelines have not standardized the sequence of diagnostic examinations during the follow-up of a patient with a diagnosed breast cancer. The aim of this study is to investigate the accuracy of sonography in the diagnosis of loco-regional lymphatic recurrences in comparison to the core needle biopsy results. Materials and Methods: Among 6455 patients who were followed up with clinical examination, mammography and ultrasound between January 2004 and November 2011, 125 (1.93%) patients had to be investigated with a core needle biopsy of a sonographically suspicious loco-regional lymph node. Results: Among the whole series, a total of 142 ultrasound-guided core needle biopsies were performed. Follow-up for the primary tumor lasted for a median time of 6.1 years (range 1 - 27 years). Ultrasound of suspicious loco-regional lymph nodes showed a sensitivity of 89.5%, a specificity of 87.1% and a positive predictive value of 89.5%. Conclusions: In our experience, ultrasound of suspicious loco-regional lymph nodes showed good accuracy and it should be a part of the standard examinations performed during follow-up for breast cancer. 展开更多
关键词 Ultrasound loco-regional LYMPH Nodes Breast Cancer FOLLOW-UP SENTINEL Node Dissection AXILLARY Surgery
下载PDF
Globe penetration during loco-regional anesthesia: prevalence and review of cases 被引量:1
9
作者 Alba Gómez-Benlloch Maximiliano Olivera +2 位作者 Jeroni Nadal Gemma Julio Javier Elizalde 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2022年第10期1683-1690,共8页
AIM: To describe prevalence and different clinical signs and management of cases with penetrating eye injuries during loco-regional anesthesia for ophthalmic surgery. METHODS: A retrospective review of clinical record... AIM: To describe prevalence and different clinical signs and management of cases with penetrating eye injuries during loco-regional anesthesia for ophthalmic surgery. METHODS: A retrospective review of clinical records was carried out, identifying cases of globe penetration secondary to peribulbar anesthesia injection during 5 y activity in Centro de Oftalmología Barraquer. RESULTS: A total of 17 460 needle-based ocular anesthesia procedures were performed in our centre and 4 cases of globe penetration were recorded with an estimated prevalence of 0.024%. Globe penetrations were always detected in the first 24 h after surgery. Vitreous haemorrhage was found in all the cases. Two eyes presented retinal detachment and two eyes choroidal detachment(CD). The initial surgical approach was performed within the first 48 h. Silicone oil was used as tamponade in three eyes and the fourth case remained only with air. Detachments were solved successfully in all the cases. Functional results varied among cases, depending on ocular remarkable antecedent and globe penetration with or without retinal or CD.CONCLUSION: Prevalence of globe penetration during loco-regional anesthesia is low in our centre. Physicians should consider the possibility of globe penetration in eyes with postoperative atypical appearance after locoregional anesthesia. Immediate B-scan ultrasonography is recommended in suspicious cases with a dense vitreous haemorrhage. An early vitrectomy surgery in conjunction with laser or cryotherapy at the penetration sites is essential for good anatomical and functional results. 展开更多
关键词 loco-regional anesthesia peribulbar RETROBULBAR globe penetration RETINA
下载PDF
Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma
10
作者 Tsung-Han Wu Yu-Chao Wang +5 位作者 Chih-Hsien Cheng Chen-Fang Lee Ting-Jung Wu Hong-Shiue Chou Kun-Ming Chan Wei-Chen Lee 《World Journal of Gastrointestinal Surgery》 SCIE CAS 2020年第1期17-27,共11页
BACKGROUND Loco-regional therapy for hepatocellular carcinoma(HCC) during the period awaiting liver transplantation(LT) appears to be a logical approach to reduce the risk of tumor progression and dropout in the waitl... BACKGROUND Loco-regional therapy for hepatocellular carcinoma(HCC) during the period awaiting liver transplantation(LT) appears to be a logical approach to reduce the risk of tumor progression and dropout in the waitlist.Living donor LT(LDLT)offers a flexible timing for transplantation providing timeframe for well preparation of transplantation.AIM To investigate outcomes in relation to the intention of pre-transplantation locoregional therapy in LDLT for HCC patients.METHODS A total of 308 consecutive patients undergoing LDLTs for HCC between August2004 and December 2018 were retrospectively analyzed.Patients were grouped according to the intention of loco-regional therapy prior to LT,and outcomes of patients were analyzed and compared between groups.RESULTS Overall,38 patients(12.3%) were detected with HCC recurrence during the follow-up period after LDLT.Patients who were radiologically beyond the University of California at San Francisco criteria and received loco-regional therapy as down-staging therapy had significant inferior outcomes to other groups for both recurrence-free survival(RFS,P < 0.0005) and overall survival(P= 0.046).Moreover,patients with defined profound tumor necrosis(TN) by locoregional therapy had a superior RFS(5-year of 93.8%) as compared with others(P= 0.010).CONCLUSION LDLT features a flexible timely transplantation for patient with HCC.However,the loco-regional therapy prior to LDLT does not seem to provide benefit unless a certain effect in terms of profound TN is noted. 展开更多
关键词 Hepatocellular carcinoma loco-regional therapy Living donor liver transplantation OUTCOMES Tumor necrosis Liver transplantation
下载PDF
Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia
11
作者 Antonio Macrì Anna Fortugno Edoardo Saladino 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2011年第12期169-174,共6页
The evolution of loco-regional treatments has occurred in the last two decades and has deeply changed the natural history of primitive and secondary peritoneal surface malignancies.Several phase Ⅱ-Ⅲ studies have pro... The evolution of loco-regional treatments has occurred in the last two decades and has deeply changed the natural history of primitive and secondary peritoneal surface malignancies.Several phase Ⅱ-Ⅲ studies have proved the effectiveness of the combination of cytoreductive surgery with peritoneal chemohyperthermia.Cytoreductive surgery allows the reduction of the neoplastic mass and increases tumoral chemosensitivity.The development of chemohyperthermia finds its origins in the necessity to exceed the limits of intraperitoneal chemotherapy performed in normothermia.It permits a continuous high concentration gradient of chemotherapeutic drugs between the peritoneal cavity and the plasma compartment to and a more uniform distribution throughout the abdominal cavity compared to systemic administration. 展开更多
关键词 Hyperthermic INTRAPERITONEAL chemotherapy PERITONEAL surface MALIGNANCIES PERITONEAL CARCINOMATOSIS Cytoreductive surgery loco-regional TREATMENTS
下载PDF
Radiological imaging and non-surgical local treatments for cholangiocarcinoma
12
作者 Angelo Della Corte Ettore Di Gaeta +1 位作者 Stephanie Steidler Francesco De Cobelli 《Hepatoma Research》 2022年第1期50-64,共15页
Cholangiocarcinoma(CC)is a malignancy with a very heterogeneous spectrum of morphopathological and prognostic characteristics.Diagnostic imaging is fundamental for early detection,preoperative staging,and resectabilit... Cholangiocarcinoma(CC)is a malignancy with a very heterogeneous spectrum of morphopathological and prognostic characteristics.Diagnostic imaging is fundamental for early detection,preoperative staging,and resectability assessment,as well as early recognition of prognostic factors.Radical surgical treatment is limited by disease stage and technical feasibility.Interventional radiology has acquired a critical function in addressing disease control and survival improvement through loco-regional therapies,specifically in the setting of intrahepatic CC.In this review,we will describe the current state of art of diagnostic imaging,focusing on intrahepatic CC and proximal extrahepatic CC,and delineate the available loco-regional therapies strategies for unresectable intrahepatic CC. 展开更多
关键词 CHOLANGIOCARCINOMA diagnostic imaging loco-regional therapies ablation EMBOLIZATION
原文传递
Impact and the delivery of loco-regional treatment for hepatocellular carcinoma during the COVID-19 pandemic
13
作者 Guo Yuan How Uei Pua 《Journal of Interventional Medicine》 2022年第4期180-183,共4页
Hepatocellular carcinoma(HCC)is the second most lethal tumour,with therapies broadly divided into curative and palliative intent.Unfortunately,the majority of HCCs were found to be unresectable at diagnosis.Advances i... Hepatocellular carcinoma(HCC)is the second most lethal tumour,with therapies broadly divided into curative and palliative intent.Unfortunately,the majority of HCCs were found to be unresectable at diagnosis.Advances in novel loco-regional therapies have given patients with unresectable HCC a vital chance for disease control and survival.However,the COVID-19 pandemic has greatly shaped and impacted treatment protocols and delivery for HCC patients.This review article aims to describe the impact of the COVID-19 pandemic on the delivery of locoregional treatment modalities for HCC and compare treatment trends between the pre-pandemic and pandemic eras.Treatment of HCC involves complex collaboration between clinical professionals within their local and global healthcare institutions.The COVID-19 pandemic has had a profound impact on the treatment of HCC.The delivery of loco-regional treatment for HCC will need to adapt to each healthcare system’s unique structure. 展开更多
关键词 Hepatocellular carcinoma Interventional Radiology Interventional Oncology Y90 loco-regional
下载PDF
Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
14
作者 Kylie E Zane Paul B Nagib +2 位作者 Sajid Jalil Khalid Mumtaz Mina S Makary 《World Journal of Hepatology》 2022年第5期885-895,共11页
Hepatocellular carcinoma(HCC)is the most common cause of liver malignancy and the fourth leading cause of cancer deaths universally.Cure can be achieved for early stage HCC,which is defined as 3 or fewer lesions less ... Hepatocellular carcinoma(HCC)is the most common cause of liver malignancy and the fourth leading cause of cancer deaths universally.Cure can be achieved for early stage HCC,which is defined as 3 or fewer lesions less than or equal to 3 cm in the setting of Child-Pugh A or B and an ECOG of 0.Patients outside of these criteria who can be down-staged with loco-regional therapies to resection or liver transplantation(LT)also achieve curative outcomes.Traditionally,surgical resection,LT,and ablation are considered curative therapies for early HCC.However,results from recently conducted LEGACY study and DOSISPHERE trial demonstrate that transarterial radio-embolization has curative outcomes for early HCC,leading to its recent incorporation into the Barcelona clinic liver criteria guidelines for early HCC.This review is based on current evidence for curativeintent loco-regional therapies including radioembolization for early-stage HCC. 展开更多
关键词 Hepatocellular carcinoma loco-regional therapy Radiation segmentectomy Transarterial radio-embolization Ablation Transarterial chemo-embolization Curative intent
下载PDF
局部复发性鼻咽癌的临床病理学特征 被引量:9
15
作者 雍娟娟 吴秋良 +5 位作者 宗永生 侯景辉 梁建中 匡亚玲 奚少彦 卢佳斌 《临床与实验病理学杂志》 CAS CSCD 北大核心 2014年第4期389-392,共4页
目的 探讨局部复发性鼻咽癌的临床病理学特征。方法 收集46例局部复发性鼻咽癌和63例原发性鼻咽癌活检组织,行HE染色、免疫组化、EBERs原位杂交检测。结果 局部复发性鼻咽癌中p63和CK5/6的强阳性表达率均高于原发性鼻咽癌(P=0.005和P=0... 目的 探讨局部复发性鼻咽癌的临床病理学特征。方法 收集46例局部复发性鼻咽癌和63例原发性鼻咽癌活检组织,行HE染色、免疫组化、EBERs原位杂交检测。结果 局部复发性鼻咽癌中p63和CK5/6的强阳性表达率均高于原发性鼻咽癌(P=0.005和P=0.026); Ki-67的强阳性表达率差异无显著性(P=0.387); 组织坏死、炎性渗出和间质促纤维增生明显; 畸形瘤巨细胞多见,癌细胞鳞状分化程度更高。5例复发性鼻咽癌细胞EBERs原位杂交和LMP-1免疫组化标记均为阴性。结论(1)局部复发性鼻咽癌有2个复发间歇高峰,即2~5年和9~11年。(2)局部复发性鼻咽癌细胞p63和CK5/6强阳性表达率、鳞状分化程度更高,侵袭性更强。(3)10.87%(5/46)的局部复发性鼻咽癌细胞EBERs原位杂交和LMP-1免疫组化标记均为阴性。 展开更多
关键词 鼻咽肿瘤 局部复发性鼻咽癌 病理学特征 免疫组织化学
下载PDF
超声剪切波弹性成像定量参数对乳腺癌系统性治疗后局部区域复发的预测价值 被引量:3
16
作者 赵巧英 赵冰 +2 位作者 吴刚 范志娜 马丙鑫 《中华实用诊断与治疗杂志》 2023年第4期377-382,共6页
目的观察乳腺癌患者系统性治疗后1年内局部区域复发(loco-regional recurrence,LRR)情况,探讨超声剪切波弹性成像(shear wave elastography,SWE)定量参数对乳腺癌患者系统性治疗后1年内发生LRR的预测价值。方法120例乳腺癌患者均给予系... 目的观察乳腺癌患者系统性治疗后1年内局部区域复发(loco-regional recurrence,LRR)情况,探讨超声剪切波弹性成像(shear wave elastography,SWE)定量参数对乳腺癌患者系统性治疗后1年内发生LRR的预测价值。方法120例乳腺癌患者均给予系统性治疗(新辅助化疗+单纯乳房切除术+术后放疗等),治疗后随访1年,根据是否发生LRR分为复发组30例和未复发组90例;乳腺良性结节患者60例为对照组。3组患者均行乳腺常规超声和实时SWE检查,比较3组乳腺常规超声声像特征及SWE定量参数[病灶及病灶周围1、2、3 mm范围内最大弹性模量值(maximum elastic modulus,Emax),分别记为A-Emax、Shell1Emax、Shell2Emax、Shell3Emax],比较复发组与未复发组肿瘤直径、淋巴结转移等临床病理特征;采用多因素logistic回归分析乳腺癌患者系统性治疗后1年内发生LRR的影响因素;绘制ROC曲线,评估SWE定量参数预测乳腺癌患者系统性治疗后1年内发生LRR的效能。结果复发组形态不规则、边缘不规整、回声不均匀、无包膜比率(96.67%、90.00%、96.67%、93.33%)及A-Emax、Shell1Emax、Shell2Emax、Shell3Emax[(130.23±14.25)、(166.84±17.52)、(173.39±18.54)、(174.89±18.56)kPa]均高于未复发组[78.89%、68.89%、81.11%、75.56%、(121.51±13.47)kPa、(158.48±16.22)kPa、(162.99±18.43)kPa、(163.89±17.84)kPa)]、对照组[21.67%、18.33%、33.33%、16.67%、(86.58±9.24)kPa、(98.86±10.62)kPa、(108.86±12.15)kPa、(112.39±13.21)kPa](P<0.05),未复发组均高于对照组(P<0.05)。复发组肿瘤直径>3 cm、有淋巴结转移、人表皮生长因子受体-2表达阳性、病理N分期ypN_(2-3)期、新辅助化疗周期数≤6个比率(53.33%、66.67%、66.67%、50.00%、60.00%)均高于未复发组(30.00%、41.11%、40.00%、24.44%、37.78%)(P<0.05)。肿瘤直径>3 cm(OR=2.236,95%CI:1.121~4.368,P<0.001)、有淋巴结转移(OR=1.854,95%CI:1.286~3.784,P<0.001)、人表皮生长因子受体-2表达阳性(OR=2.347,95%CI:1.48 展开更多
关键词 乳腺癌 系统性治疗 局部区域复发 超声剪切波弹性成像 最大弹性模量值
原文传递
每周奥沙利铂或顺铂同期放化疗治疗局部晚期鼻咽癌的随机对照研究 被引量:6
17
作者 黄海欣 黄东宁 +1 位作者 陈绍俊 李桂生 《徐州医学院学报》 CAS 2009年第6期366-368,共3页
目的研究奥沙利铂或顺铂与放疗同步进行治疗局部晚期鼻咽癌的临床疗效和毒副反应。方法76例局部晚期鼻咽癌随机分成2组:奥沙利铂治疗组39例,顺铂对照组37例。2组均接受常规放射治疗。化疗方案:奥沙利铂治疗组70 mg/m2,顺铂对照组30 mg/... 目的研究奥沙利铂或顺铂与放疗同步进行治疗局部晚期鼻咽癌的临床疗效和毒副反应。方法76例局部晚期鼻咽癌随机分成2组:奥沙利铂治疗组39例,顺铂对照组37例。2组均接受常规放射治疗。化疗方案:奥沙利铂治疗组70 mg/m2,顺铂对照组30 mg/m2,均为每周静滴1次。结果奥沙利铂治疗组和顺铂对照组鼻咽肿瘤及颈部淋巴结完全消退率无显著性差异(P>0.05)。中位随访24个月后,2年无转移生存率奥沙利铂组为89.74%,顺铂组为91.89%;2年无复发生存率奥沙利铂组为92.31%,顺铂组为94.59%;无转移生存率及无复发生存率以顺铂组稍高,但与奥沙利铂组相比差异无显著性(P>0.05)。Ⅲ、Ⅳ级恶心呕吐发生率以顺铂组显著(P<0.05);外周神经毒性以奥沙利铂组显著(P<0.05),但均为Ⅰ、Ⅱ级。其余毒副反应以顺铂组稍高,但无统计学意义(P>0.05)。结论奥沙利铂同步放化疗治疗局部晚期鼻咽癌疗效与顺铂相似,奥沙利铂胃肠道反应发生率低,患者更易耐受。 展开更多
关键词 局部晚期鼻咽癌 同期放化疗 奥沙利铂 顺铂
下载PDF
结直肠癌肝转移手术切除及全身、区域化疗 被引量:4
18
作者 梁廷波 耿磊 《中国实用外科杂志》 CSCD 北大核心 2011年第11期1000-1003,共4页
结直肠癌肝转移发病率高,是结直肠癌的常见死亡原因。其主要治疗方法有手术切除和全身化疗与区域化疗,而手术切除是提高存活率的关键。目前,结直肠癌肝转移以手术治疗为核心的综合治疗体系已经形成,然而,手术切除与全身、区域化疗的科... 结直肠癌肝转移发病率高,是结直肠癌的常见死亡原因。其主要治疗方法有手术切除和全身化疗与区域化疗,而手术切除是提高存活率的关键。目前,结直肠癌肝转移以手术治疗为核心的综合治疗体系已经形成,然而,手术切除与全身、区域化疗的科学选择是进一步提高该类病人存活率和使病人获得最大收益的关键。 展开更多
关键词 结直肠癌 肝转移 全身化疗 区域化疗
原文传递
治疗前不同血浆EB病毒DNA水平对非高发区鼻咽癌患者预后影响的研究 被引量:3
19
作者 张晶晶 岳成山 +6 位作者 刘亚军 王会霞 高山 张强 张蕾 胡勇 张明秀 《中国病毒病杂志》 CAS 2021年第5期363-369,共7页
目的探讨血浆EB病毒(Epstein-Barr virus,EB)潜伏和活化状态对非高发区鼻咽癌患者预后的影响。方法对陕西省汉中市(非鼻咽癌高发区)中心医院2014年8月1日—2017年7月31日收治的318例鼻咽癌患者于治疗前进行EB病毒DNA水平定量检测,以治疗... 目的探讨血浆EB病毒(Epstein-Barr virus,EB)潜伏和活化状态对非高发区鼻咽癌患者预后的影响。方法对陕西省汉中市(非鼻咽癌高发区)中心医院2014年8月1日—2017年7月31日收治的318例鼻咽癌患者于治疗前进行EB病毒DNA水平定量检测,以治疗前EB病毒DNA定量≥500拷贝/ml为界值将患者分为EB病毒DNA阳性(EB病毒活化状态)组(n=199)和阴性(EB病毒潜伏状态)组(n=119),采用倾向值匹配法获得EB病毒DNA阳性组和EB病毒DNA阴性组各项资料均衡的鼻咽癌患者228例(1∶1匹配)。采用Kaplan-Meier法计算生存率,采用Cox回归模型进行预后因素分析。主要研究终点为无进展生存率(failure-free survival,FFS),次要研究终点为总生存率(overall survival,OS)、无局部区域进展生存率(loco-regional relapse-free survival,LRFS)和无远处转移生存率(distant metastasis-free survival,DMFS)。结果318例患者中,119例(37.4%)EB病毒DNA定量阴性鼻咽癌患者预后优于EB病毒DNA定量阳性组患者(3年FFS:90.3%vs 74.8%,χ^(2)=7.193,P=0.007;OS:92.7%vs 87.8%,χ^(2)=3.187,P=0.074;LRFS:95.3%vs 86.5%,χ^(2)=4.521,P=0.033;DMFS:95.8%vs 85.7%,χ^(2)=6.033,P=0.014)。用倾向值匹配法纳入的228例患者中,EB病毒DNA阴性组对比阳性组,3年FFS、OS、LRFS和DMFS分别为:89.9%vs 67.5%,χ^(2)=4.258,P=0.039;92.3%vs 88.7%,χ^(2)=1.210,P=0.271;95.1%vs 76.4%,χ^(2)=4.598,P=0.032和95.6%vs 86.9%,χ^(2)=2.665,P=0.103;Cox回归模型显示EB病毒DNA阳性是FFS、LRFS和DMFS的不良预后因素。结论EB病毒呈潜伏状态的非高发区鼻咽癌患者预后更好。 展开更多
关键词 鼻咽癌 EB病毒 DNA 预后 倾向值匹配法 无进展生存率 总生存率 局部区域进展生存率 无远处转移生存率
原文传递
乳腺癌局部区域复发病灶受体状态检测及对后续治疗的指导价值 被引量:2
20
作者 陆裕杰 金泽宇 +3 位作者 李亚芬 沈坤炜 陈伟国 陈小松 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2019年第9期1071-1076,1071,共6页
目的·分析局部区域复发(loco-regional recurrence,LRR)乳腺癌患者原发灶和LRR 病灶雌激素受体(estrogen receptor, ER)、孕激素受体(progesterone receptor,PR)、人类表皮生长因子受体-2(human epidermal growth factor receptor-... 目的·分析局部区域复发(loco-regional recurrence,LRR)乳腺癌患者原发灶和LRR 病灶雌激素受体(estrogen receptor, ER)、孕激素受体(progesterone receptor,PR)、人类表皮生长因子受体-2(human epidermal growth factor receptor-2,HER-2)和增殖细胞核抗原Ki67 状态的符合率及对后续治疗的影响。方法·回顾性分析2009 年1 月-2018 年9 月,在上海交通大学医学院附属瑞金医院乳腺疾病诊治中心接受乳腺癌手术治疗,随访发生单纯LRR 的乳腺癌患者。对原发灶和LRR 病灶进行ER、PR、HER-2 和 Ki67 状态检测,分析两者之间的一致性及后续治疗的选择。结果·在7 823 例接受手术乳腺癌患者中,有106 例发生单纯LRR,其中 56 例患者LRR 病灶检测了ER、PR、HER-2 和Ki67 状态,其阳性率分别为48.2%、25.0%、35.2%和81.5%,与原发灶的符合率分别为76.8%、76.8%、89.1%和77.8%,κ值分别为0.538、0.469、0.729 和0.402。共有18 例患者激素受体(ER 或PR)(14 例)和/或 HER-2(6 例)状态发生改变:9 例激素受体状态由阳性变为阴性,其中4 例未接受后续内分泌治疗;4 例患者HER-2 状态由阴性变为阳性,其中1 例接受后续抗HER-2 靶向治疗。结论·乳腺癌原发灶与LRR 病灶的ER、PR 和Ki67 存在中度一致性,而HER-2 的一致性较高;LRR 病灶受体状态的改变会影响其后续治疗方案的选择。 展开更多
关键词 乳腺癌 局部区域复发 雌激素受体 孕激素受体 人类表皮生长因子受体-2 一致性分析 治疗
下载PDF
上一页 1 2 下一页 到第
使用帮助 返回顶部